Equity Field Notes from temporal sources

[DanWebzster]

TTOO

Pipeline consists of 4 products (not including Hemostat instrument):

1. FungalCandida Panel (CE marked & FDA cleared) presently marketed
Panel expansion in progress
2. Bacterial Panel (CE marked & FDA submitted) Awaiting FDA
clearance by 3/31/18
3. Bacterial Resistance Markers (Partnered with Allergan)
4. LymePanel (Partnered with Canon)

Cash and Credit Line will last into Q1 2019.

Expect financing if Bacterial Panel approved

Has gone thru 4 CFOs since it went public in 2014.

FUBAR loss of credit line, if Bacterial Panel not approved by end of April.

High Risk High Reward trade into 510(k) clearance by 3/31.